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Abstract 
Candida albicans commonly infect medically implanted devices. To combat C. albicans’ 
increasing resistance to current treatment methods, a preventative measure was developed by 
incorporating Filastatin into silicone catheters. Filastatin was shown to inhibit the adhesion of cells by 
constraining the development of hyphae that allow the cells to adhere to one another and to surfaces. 
Different drug incorporation methods were developed and tested to determine the best way to utilize 
Filastatin in order to inhibit C. albicans from adhering to silicone urinary catheters.  
4 
 
Background 
Candida albicans is the fourth most common source of hospital-acquired infections in the 
United States (Wisplinghoff et al., 2004). It primarily affects immunocompromised individuals with a 
thirty to fifty percent mortality rate (Pappas et al., 2003). C. albicans can cause two types of infections: 
mucosal infections (oral and vaginal thrush) and systemic infections (candidemia) (Fidel and Sobel, 
1996). These infections usually reside from medical devices including catheters, prosthetics, grafts, and 
cardiac devices (Kojic & Darouiche, 2004). The estimated annual cost of treating a systemic C. albicans 
infection exceeds $200 million per year due to its increasing resistance to antifungal drugs (Millar et. al, 
2001). C. albicans is becoming resistant to first-line and second-line antifungal medications, namely, 
Pyrimidine, Azoles, Polyenes and Echinocandins (Morgan, 2005). For example, approximately seven 
percent of all Candida bloodstream isolates tested at the Center for Disease Control (CDC) are resistant 
to fluconazole (a type of azole) (Cleveland et al., 2012). Overall, antifungal resistance is becoming more 
and more of an issue. It will continue to worsen unless more is done to prevent further resistance and 
the spread of these infections.  
C. albicans cells are not harmful at 30°C, 5.4 pH and remain as single round budding yeast cells 
(blastospore). It is only once they are induced by several environmental conditions including pH, 
temperature, or a carbon lacking environment that they pose a threat to humans. (Fazly et. al., 2013) 
Once the C. albicans are induced, they start filamentation in which the cells form small projections called 
“germ tubes” and continue to divide at the apical tip of the tubes to form extended filaments or hyphae 
(Odds, 1988; Lo et al., 1997; Brown, 2002; Saville et al, 2003). Hyphae allow the cells to adhere to 
implanted medical devices and human epithelial cells by exerting force from the growth of the apical tip 
of the tubes on the surfaces (Kumamoto and Vinces, 2005). This same force allows the cells to adhere to 
one another and form biofilm over the surface with which they come into contact. Biofilm is a 
polysaccharide extracellular matrix produced by the cells in order to shield them from external threats 
5 
 
like antibodies and antibiotics (Chandra et al., 2001). Biofilm formation is harmful because once it forms 
on a medical device, the device is difficult to remove and can cause diseases as described previously. 
These medical devices often have to be surgically removed (Chauhan, 2012). 
Urinary catheters are the most commonly used devices in the U.S. that acquire C. albicans 
infections (Kojic & Darouiche, 2004). They have the greatest overall infection rate between 10-30%. A 
urinary catheter is a tube placed in the body to collect and drain urine from the bladder. Catheters come 
in various sizes, plastics and types (Lawrence and Turner, 2005). The most common catheter plastics are 
latex, thermoplastic polyurethane and silicone. There are two main types of catheters: indwelling and 
intermittent.  
Indwelling urinary catheters can be left in the bladder for either a short (<14 days) or long 
period of time (>14 days) (Pickard et al., 2012). An indwelling catheter collects urine by attaching to a 
drainage bag. Recently developed catheters have valves that can be opened to allow urine to flow out. 
An indwelling catheter may be inserted into the bladder in two ways. Most often, the catheter is 
inserted through the urethra. This is the tube that carries urine from the bladder to the outside of the 
body. Sometimes, the provider will insert a catheter into your bladder through a small hole in your 
abdomen. Intermittent urinary catheters are used when the individual only needs the catheter for a 
short period (a matter of hours) or they do not want to wear a bag (Wilde et al., 2011). The individual 
will insert the catheter to drain the bladder and then remove it him/herself. The highest incidence of 
healthcare-associated infection is associated with long-term indwelling catheterization (National 
Institute for Clinical Excellence (NICE), 2012). 
To combat the increasing resistance of C. albicans to typical treatment methods, scientists 
including Dr. Paul Kaufman at the University of Massachusetts conducted a high-throughput phenotypic 
screening of small molecules to identify compounds that inhibit adhesion of C. albicans to polystyrene 
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plates (Fazly, 2013). Adhesion is the first step of the pathogenesis of C. albicans, and without it, the 
fungus cannot form pathogenic biofilm. From the screening of small molecules, they found a candidate 
that prevented C. albicans’ adhesion called Filastatin (Fazly, 2013). Screening was conducted by co-
incubating molecules with cells grown in Spider media (a carbon-lacking media that induces hyphal 
formation) and quantifying how many cells adhered to the surface. What they found was that Filastatin 
significantly decreased the amount of cells adhering to the various surfaces from 50-75%. Assays 
comparing the effect of co-incubating cells with Filastatin, after 8 hours of cells incubating alone, 
showed that Filastatin also has an effect on cells already bound to a surface. These tests showed that 
Filastatin affects hyphal formation, which in turn, affected biofilm formation (Fazly, 2013).  
Filastatin diminishes yeast-to-hyphal transformation and therefore reduces fungal pathogenesis. 
The exact mechanism for the interaction between Filastatin and C. albicans is unknown. It is 
hypothesized that it is caused by disrupting multiple signaling pathways. The first pathway is the cAMP-
PKA pathway which causes hyphal induction by Spider media. Cells constantly overexpressing the G 
protein-coupled receptor Gpr1 became hyperfilamentous in Spider media by PKA stimulation, and 
Filastatin inhibits this. PKA pathway stimulation also drives transcription factor Efg1 phosphorylation, 
activating Efg1 to increase expression of genes required for hyphal morphogenesis. This was confirmed 
with an experiment that involved hyperactive Ras1 signaling protein mutant, another upstream signal 
that governs hyphal development. When Filastatin was introduced to the Spider media with the 
modified cells, the inhibitory effect was comparable to that of WT cells. 
 Other experiments suggested that Filastatin affected more than one signaling pathway. For 
example, the modified sugar GlcNac stimulates hyphal morphogenesis independently of the cAMP-PKA 
pathway; instead, it activates the transcription factor Cph1 (Midkiff and White, 2013). On testing 
morphogenesis driven by GlcNac-containing media or constitutive overexpression of Cph1, Fazly’s lab 
found that Filastatin still inhibited hyphal formation.  
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 Filastatin’s effects on C. albicans’ morphogenesis have been clearly documented but not 
understood to the extent that it can be used to treat patients. C. albicans infections have been identified 
as a public health issue (Pfaller 2007), but it could take years for Filastatin to be used therapeutically. 
There are various drugs as well as antifungal treatments used to prevent infection, but these are 
becoming ineffective quickly (Pfaller 2007).  
Materials and compounds capable of inhibiting C. albicans adhesion onto medical materials 
have been identified as the best preventative measure (Palza, 2015) (Zhou, et al., 2010) (Onaizi, 2011). 
These material or compounds can have several incorporation strategies to transfer their antifungal 
properties to the medical material. Four of the most common drug incorporation methods are 
polymerization, simple coating, absorption, and controlled release via the layer of polymers.  
One example of polymerizing a drug into a medical material is the incorporation of ester and 
cyclic hydrocarbon moieties into silicone. Silicone polymerized with these molecules reduced adhesion 
of three pathogenic bacteria by 96% (Hook et al., 2012). These results were demonstrateed in vitro with 
lesser results in a mouse model. While these methods were effective with bacteria strains, similar 
results have yet to been seen with C. albicans.  
 Parylene is an example of an antimicrobial simple coating method. It is used to coat many 
different surfaces including metal, glass, paper, resin, plastic, and ceramic by chemical vapor deposition 
and polymerization of pare-xylene (Demirel, 2008). Parylene is thought to cut the bond between silanol 
groups (Si-OH), like those between the silicone on the surface and hydrogen atoms of proteins on the C. 
albicans’ surface (Zhou, et al., 2010).  C. albicans adhesion to silicone elastomer surfaces coated with 
Parylene is less than uncoated samples, on the magnitude of 4.5x fewer cells (2.18 x 107 uncoated vs. 
0.48 x 107 coated) (Zhou, et al., 2010).  
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 Although effective in limiting C. albicans’ adhesion, there are some issues associated with this 
coating technique. One includes the moisture barrier performance. Parylene moisture barriers are 
susceptible to failure after prolonged exposure at higher temperatures. Under such conditions, 
resistance to corrosion can decline due to contaminants or particles trapped inside the coating-film (Li, 
et al., 2008). Parylene’s biggest flaw is adhesion to the surface being coated. Coating can only be done 
on devices that will fit in the deposition system's coating chamber (Li, et al., 2008). Furthermore, while 
Parylene coatings are typically thin, they also deposit relatively slowly; it would take over an hour to 
deposit enough parylene onto the surface of silicone (Tooker 2007).   
Absorption of drugs by plastics was effective in preventing C. albicans infections. One study used 
fluconazole loaded polyurethane with pore-forming agents (Donelli, 2009). The hope was to release the 
antifungal drug over time, inhibiting fungal biofilm formation on medical devices. By releasing the drug 
over time, the local drug concentration at the surface remains high enough to inhibit pathogenesis for a 
longer time. Fluconazole was adsorbed in higher amounts by the most hydrophilic polymers and its 
release was influenced by the degree of polymer swelling in water. Drug release was noticeable through 
UV spectroscopy at 215 nanometers up to nine days after incubation with C. albicans. This method 
inhibited C. albicans growth and biofilm formation (undetectable cell count) on polymeric surfaces for 
up to eight days.  
There are a few issue associated with this method. One is that the polymer uses fluconazole as 
the antifungal agent. Fluconazole is a type of azole which, among other antifungal agents, has increased 
resistance by C. albicans. In addition, this treatment method elutes fluconazole for a nine day period 
with no detectable biofilm formation for only eight days. Indwelling long-term catheters can be 
implanted for up to month (Saint and Lipsky, 1999), so this coating method would not work for these 
types of catheters.  
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The final method is controlled release. A study involving the controlled-release method released 
silver ions through a polydopamine film. Metals can be extremely toxic to bacteria and yeast at 
exceptionally low concentrations (3-5% of the total composition of the polymer) (Palza, 2015). 
Polydopamine is a self-polymerizing molecule that forms a thin adherent film on virtually any surface 
under mild alkaline aqueous conditions and in the presence of oxygen. Moreover, exposed reactive 
groups of the polydopamine coatings enable further functionalization of the coatings through covalent 
grafting of polymers and allow reduction of metal ions to be released (Lee, 2007). Sustained silver 
release was observed for a little over 7 days from silver-coated substrates, and the release kinetics could 
be modulated via additional polydopamine overlayers. In vitro functional assays employing both gram 
negative and positive strains demonstrated dual fouling resistance and antibacterial properties of the 
coatings due to the antibacterial effect of silver. Silver ions in vivo have not produced effective results, 
as expressed by what is currently on the market. 
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Materials and Methods 
Incorporating Filastatin 
Filastatin incorporation was measured using absorbance. In a 24-well plate, plastic squares (0.8 
x 0.8 cm.) were placed in 1.5 ml of 25uM Filastatin in Tris buffer. The plate was then placed on a rotator 
at roughly 80 RPM at room temperature and at various time points from 0 to 2880 min (2 days); 1 ml of 
solution was taken out and measured using a spectrophotometer at 400 nanometers. The 1 ml of 
solution was put back into the plate each time and allowed to continue rotating. Absorbance readings 
were recorded in an Excel document and plotted against time. To make sure that the concentration of 
Filastatin correlated well with the absorbance at 400 nm, a standard curve was created. Filastatin was 
serially diluted from 25uM to 1.5uM using 10uM Tris pH 8.5 to make sure that the small amount of 
molecules that were eluted over time could be measured. The absorbance reading correlated linearly 
with concentration (R2 = 0.9897). Based off of this correlation, approximate concentration in solution 
can be calculated. 
Yeast Culture and Maintenance  
The cells used for this experiment were the SC5314 strain of C. albicans. This wild-type strain is 
more filamentous and more invasive than other wild-type strains of C. albicans (like VE175) and 
representative of strains that would be most likely seen in a hospital (Hua et al., 2009). The cells were 
grown on a yeast peptone dextrose (YPD) agar plate. Individual colonies were grown in supplemented 
YNB broth (Yeast Nitrogen Broth + 2 % glucose + 0.1 mg/ml uridine), in a 30oC shaker at 140RPM for up 
to 24 hours (Daniels et al., 2013). The OD of the culture was measured at 12 hours and adjusted so that 
the cells remained in log phase. In order to induce filamentation during incubation with samples, spider 
media (1% Difco nutrient broth, 1% mannitol, 0.2% dibasic potassium phosphate, pH 7.2) was used and 
the cells were incubated at 37oC in a shaker at 80RPM (Daniels et al., 2013). 
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Preparing Samples 
 Plastic samples were cut from either a silicone sheet or a silicone catheter. Samples were cut to 
size (0.8 cm squares or 2 x 11 mm rings) using a razor blade and then sterilized by immersion in ethanol. 
Samples were weighed to assure that they were equal by mass. The samples were soaked in ethanol 
after being cut to keep them clean. On the day that they were to be used for the cell adhesion assay 
they underwent four doses of UV radiation at a radiant exposure of 3 mJ/cm2 (Dai et al., 2011).  
 
Measuring Cell Adhesion 
Cell adhesion was measured by testing C. albicans’ ability to stick to the catheter plastics.  Cells 
were incubated with the samples at 37°C rotating at 80RPM.  One Optical Density (OD) of C. albicans at 
600 nm wavelength is approximately 3 x 107 cells. The cell density for the initial assays was 0.3 OD/ml 
(total 0.45 OD), based off a cell seeding experiment on silicone elastomers (Chandra, Jyotsna, et al., 
2001). The final assays used a starting cell count of 1000 cells per milliliter to more closely mirror the 
minimum infectious does of C. albicans.  
 
Cell Staining 
Crystal violet, a triarylmethane dye that stains DNA within cells and has an absorbance around 
590 nm, was used for cell quantification after incubation (Adams and Ludwig, 1914). Samples were 
removed from the 24-well plate in which they were incubated and washed using PBS. Samples were 
submerged in 1.5 mL PBS for five minutes on a rotator at roughly 80RPM. The samples were moved into 
a fresh 24-well plate and 800 uL of crystal violet was added directly to each sample.  After incubating 
cells with crystal violet for 15 minutes, the samples were washed again using PBS. Three consecutive 
washes were done, aspirating the PBS each time. Washes were done to assure that any crystal violet 
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remaining had effectively stained only cells that had adhered to the samples. Samples were next 
submerged in 750 uL of acetic acid in 1.5 mL Eppendorf tubes to remove the crystal violet from the 
sample. The tubes were vortexed until the samples were no longer stained. Absorbance readings were 
measured in duplicate by reading 100 uL of acetic acid in a 96-well plate. Absorbance readings were 
measured in duplicate to measure the approximate number of cells in the sample.   
Analysis 
Outliers from the absorbance readings were identified using Turkey’s boxplot (Rousseeuw, 
2011). The interquartile distance from the upper and lower quartiles of data were multiplied by 1.5 
(1.5*IQR). The interval or “fence” is defined as the upper quartile plus 1.5*IQR and the lower limit minus 
1.5*IQR. Any values outside this range were labeled as outliers and rejected. The computations for this 
were carried out using excel. Next, background readings were subtracted from the readings. Background 
was a control sample that measured either the fluorescence or absorbance of the dye itself when no 
cells were present.  
The growth of cells during the cell adhesion assays was slightly different from experiment to 
experiment. In order to be able to compare the results of each experiment to one another, the data was 
later normalized to the uncoated control samples. Normalization allowed for comparative decreases to 
be compared between conditions and experiments. The data was plotted with a standard error bar to 
explore variability within a condition between experiments. Lastly, a T-test and an ANOVA were 
conducted to prove statistical significance or difference between different conditions, most specifically 
comparing samples containing Filastatin to the controls. 
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Long Term Simulated in vivo Testing  
 The OD/mL used in the previously described experiments, 0.3, is higher than any cell count that 
would cause infections in humans. The 2.5 hour incubation period is significantly shorter than the time 
that catheters are left in patients. To address these problems, a long term assay was conducted. The 
goal with this assay was to more closely simulate the conditions a catheter would be exposed to while 
operating within the constraints of our lab. The same cell adhesion assay using crystal violet was used. 
 The initial cell count used was 1000 cells per mL, or 0.000001 OD/mL. The experiment was set 
up such that each condition occupied a 24 well plate. This cell count was chosen to more closely 
simulate the number of cells found in vivo. At 24 and 48 hours, six samples were removed. There were 
duplicate samples for the 48 hour reading; one to show the effects of washing and one to determine the 
effects of prolonged incubation. Washing the final set of samples consisted of removing one mL from 
each well and replacing it with fresh spider media. These extracts were measured to track the change in 
OD over two days. Washing slowed the growth of the cells as well as simulate movement of urine 
through the urethra.  
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Results 
Designing a method of incorporating Filastatin into plastics already used for urinary catheters 
would decrease C. albicans treatment costs around the world. Studies done at the University of 
Massachusetts by Fazly et al have demonstrated that solubilized Filastatin at a concentration of 25uM 
inhibits hyphal morphogenesis of C. albicans, effectively preventing cell adhesion and therefore 
infection. These results were found with regards to adhesion onto polystyrene plates. As promising as 
the results are, they do not indicate whether or not Filastatin can retain a therapeutic effect over a 
longer period of time or if Filastatin could be incorporated into medical grade plastics. This study aims to 
analyze these possibilities by developing an incorporation method for Filastatin into medical grade 
plastics that will significantly decrease cell adhesion for up to 48 hours. In order to test whether or not 
incorporating Filastatin was possible, experiments to reaffirming effectiveness and test the versatility of 
the incorporation method were done. After effectiveness was demonstrated, Filastatin’s elution rate 
was calculated, on the market catheters were tested, and forecasts were done to approximate the cost 
per catheter for each incorporation method. 
Cell adhesion was tested by incubating samples in Spider Media with C. albicans cells. Crystal 
violet was used to stain cells that had adhered to the samples during incubation. After releasing the 
crystal violet from the samples using acetic acid, absorbance readings were measured at 590 nm; the 
absorbance values correlated to the amount of cells adhered to the sample. Four experimental 
conditions were used along with a positive and negative control. The positive control was uncoated 
samples and the negative control was samples incubated in water without cells. Given that solubilized 
Filastatin effectively inhibited cell adhesion as demonstrated by Fazly et al, this was used as a control on 
Filastatin’s effect on the C. albicans cells. 
15 
 
 Once solubilized Filastatin proved to inhibit cell adhesion experiments were done to 
incorporate Filastatin into the samples by absorption. The samples were soaked in 25uM Filastatin in 
Tris pH 8.5 for 24 hours. The samples were incubated with cells for 2.5 hours and then stained with 
crystal violet and analyzed. Samples with Filastatin absorbed into them decreased cell adhesion by 
roughly 50% during preliminary testing (Figure 1). This incorporation method demonstrated the ability 
to significantly inhibit cell adhesion. Augmenting the release of Filastatin was the next goal of 
experimentation.  
Polydpamine was added to samples that had absorbed Filastatin as the next experimental 
condition. Polydopamine is a self-assembling polymer that was allowed to cover the samples after they 
had absorbed Filastatin for 24 hours. Samples were left in a solution of polydopamine (2mg per mL) for 
24 hours, washed, and incubated with cells for 2.5 hours. Samples coated only in polydopamine were 
included to determine whether or not the polymer alone would affect cell adhesion. Comparison of 
these conditions would determine if the two molecules would have no effect, and additive effect, or act 
synergistically. Absorbance readings from these samples are presented in Figure 1. Preliminary testing of 
samples coated with both Filastain and polydopamine resulted in approximately 65% fewer cells 
adhered to the samples. The polydopamine coating alone decreased cell adhesion by 57%.   
Each condition was replicated 18 times, adding to the inherent variability seen in the large error 
bars of some conditions.  The absorbance of the crystal violet that stained the adhered cells was 
measured at 590 nm; this is the y-axis. Each condition is compared on the x-axis. The values were 
normalized to the uncoated sample, allowing for comparison of Filastatin’s effect on cell adhesion and 
causing the uncoated condition to have an absorbance reading of one. The absorbance readings of each 
condition (excluding the controls) were not statistically different from one according to a student T test 
(95% confidence). The separate treatments had similar effects on cell adhesion after 2.5 hours of 
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incubation. This proved that the incorporation of Filastatin was effective but did not clearly show why 
Filastatin was working because polydopamine treatments had very little impact on efficacy. The 
significant effect on cell adhesion led to the decision to test the incorporation method on similar plastics 
used to make urinary catheters.  
Preliminary testing proved that the incorporation methods decreased C. albicans’ ability to 
adhere to silicone. The subsequent experiments tested two other catheter plastics, thermoplastic 
polyurethane (TPU) and pellethane, using the same incorporation methods that were effective with 
silicone. The versatility tests were done because an incorporation method that is applicable to more 
than one type of catheter plastic would make a much more significant impact on the frequency of C. 
albicans infections. Both of these plastics were acquired from Bentec Medical in the form of long sheets. 
They were comparable to silicone in rigidity, texture and opacity. The only notable difference between 
the materials during the cell adhesion assays was absorptivity; pellethane swelled more than 
thermoplastic polyurethane or silicone, especially when soaked in ethanol.  
 The same experimental conditions from the cell adhesion assay using crystal violet to stain the 
cells adhered to silicone were used for both plastics. There were no notable qualitative differences 
between the assays done on silicone and those done on TPU and pellethane. The differences between 
the assays was in the absorbance readings. Figure 2 shows that there was no noticeable change in cell 
adhesion throughout the separate conditions for pellethane; each experimental condition absorbed a 
similar amount of crystal violet. It also shows the results for the assay done with thermoplastic 
polyurethane. The decrease in adhesion on the sample coated with both Filastatin and polydopamine 
was 28.0%, not as drastic as it was on silicone (64.9%). In addition, Filastatin co-incubation had a lower 
decrease in cell adhesion on thermoplastic polyurethane than it did on pellethane (40.1% v. 66.5%). 
Neither the Filastatin incorporation nor the polydopamine treatments inhibited cell adhesion on these 
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plastics. The incorporation method used for silicone was not transferable to either of the two other 
medical grade plastics that were tested. Without the option of testing other medical grade materials, 
the focus for the next series of experiments shifted to testing the effectiveness of the incorporation 
method.  
 Qualitatively testing the incorporation of Filastatin into silicone was simple; the molecule is 
bright yellow. After allowing the samples to soak in silicone for 24 hours, they absorbed enough 
Filastatin to turn yellow. The next series of experiments were chosen in order to determine the rate at 
which the molecules were incorporated into the samples and in turn eluted. First, a standard curve for 
the concentration of Filastatin was created. Filastatin was serially diluted from a concentration of 25uM 
to 1.5uM. Absorbance values were measured at 400 nm to test the correlation between concentration 
and absorbance. Figure 3 shows that the relationship is linear with an R2 value of 0.9897. The equation 
for the trend line was used to calculate Fialastatin’s concentration in solution as it was absorbed and 
then eluted from the samples. After determining the correlation, absorption and elution tests were 
done to measure the incorporation of Filastatin into silicone samples.  
Absortion of Filastatin by silicone samples was measured by soaking the samples in 1.5 ml of 25 
uM Filastatin in Tris pH 8.5. for two days. Figure 4 shows how much Filastatin was absorbed over time 
through this experiment. The concentration of Filastatin in Tris pH 8.5 plateaued around 3uM, showing 
that Filastatin had been incorporated into the silicone. The amount of Filastatin incorporated into the 
samples was observed by periodically measuring the absorbance of Filastin at 400 nm over the course of 
two days. During the first two hours, the six samples varied greatly. The samples’ absorption began to 
converge after 24 hours, and by 48 hours they were almost exactly the same. The final Filastatin 
concentration was roughly 22uM less than where it began; the samples had each taken up 33.71 
nanomoles of Filastatin. After measuring absorption, the rate of elution was tested.  
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Once the samples had reached equilibrium with Filastatin in solution, they were moved to a 
fresh plate with 1.5 mL 10mM Tris pH8.5. The absorbance of each sample was read periodically at 400 
nm over two days. Some samples that had absorbed Filastatin were then coated in polydopamine. The 
rate of elution for the two separate conditions were compared. Figure 5 shows the release of Filastatin 
over time from each condition measured by absorbance of the solution at 400 nm. Time points up to 
720 minutes created a roughly linear elution rate of 0.833 nanomoles per hour for the silicone squares 
and 1.08 nanomoles per hour for squares coated in polydopamine after Filastatin. The elution rate that 
was measured was generated from samples prepared in the same manner as the cell adheison assay, 
making it safe to assume that 0.8 nanomoles per hour would be enough for a therapeutic effect. These 
elution values were used to calculate the theoretical cost of a Filastatin incorporated catheter.  
Determining if the incorporation method was sustainably manufacturable started with a cost 
analysis of catheter that was incorporated with Filastatin.  Cost analysis was performed to figure out 
how much money it would cost to produce one full catheter with the absorption of Filastatin and 
Filastatin with a polydopamine layer. Using the moles of Filastatin used to treat each silicone sample 
was used as the basis of the analysis. The small samples were used as the base unit for the catheter. 
Taking into consideration only the Filastatin and silicone, the total cost of treating a silicone catheter 
with Filastatin would be $9.97; the addition of polydopamine increased cost to $10.68.  The breakeven 
point was calculated to be $24.03 per catheter based on what C. albicans infections cost. The cost of this 
catheter is comparable to on the market antimicrobial catheters and less than the cost of treating one 
systemic infection.  After showing production was feasible, cell adhesion assays were repeated with 
catheter segments.  
 The silicone used in the previous assays was a sheet, the next assays tested catheter segments. 
The silicone catheter from Seeking Health™ had an outer diameter (OD) of 11 mm and inner diameter 
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(ID) of 8 mm. When testing this catheter, two options for cutting were tested: rings and curved squares. 
Rings were cut to a depth of 2mm and curved squares were cut 8 x 8 mm. Rings were chosen over 
curved square segments due to difficulty cutting the squares. Uneven square curvature lead to an 
increased error between replicates, even within the same assay. The decision to use rings was made 
after considering the results of the cell adhesion assay done as previously described. Figure 6 shows the 
same experimental conditions as the assay done using silicone sheets. In comparing the decrease in 
adhesion, the assay done using rings was 65% more effective. This is the ultimate reason that rings were 
chosen over squares. 
Cutting the rings to 2mm deep rings proved to be variable. To account for the rings not being a 
consistent shape (some were lopsided), they were weighed to assure that size was equal by mass. Once 
preliminary testing determined a proper cutting method, a cell adhesion assay was performed in 
triplicate to determine the decrease in cell adhesion for each incorporation method. The results are 
presented in Figure 7. Comparing the normalized absorbance values to the positive control revealed that 
the polydopamine coating alone had the largest decrease in cell adhesion (71.7%), followed by Filastatin 
then Polydopamine (70.5%) and Filastatin (67.6%). All of these values were statistically similar to one 
another as well as Filastatin co-incubated. These results are roughly congruent with those from the 
previous assay done using silicone sheets. Again, the incorporation of Filastatin proved to be successful 
but not different from nor affected by polydopamine treatments. Since both incorporation and 
decreasing cell adhesion were effective with catheter segments, they were used for the completion of 
the project. In order to distinguish between treatment conditions, a long term assay was chosen as the 
next stage of experimentation.  
Previous cell adhesion assays were done with a 2.5 hour incubation time and a starting cell 
count of 0.3OD per milliliter. This assay was adjusted to more closely replicate in vivo conditions. The 
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starting cell count was changed to 1000 cells per milliliter, much closer to the minimum infectious dose 
of C. albicans. Two sets of samples were incubated concurrently. Treatment with crystal violet and 
subsequent absorbance readings were done at 22 hours and 45 hours. The hope of a longer incubation 
time was to distinguish between treatment methods; results are presented in Figure 8. The 22 hour 
reading demonstrated that Filastatin, both absorbed and in soluble form, had an expected effect on cell 
adhesion. Filastatin in solution decreased cell adhesion by a third and Filastatin absorbed into the 
samples halved cell adhesion. The polydopamine treatments had an adverse effect, the absorbance of 
crystal violet was higher than the positive control. The samples that were read at 45 hours produced 
different results. Polydopamine treatments did not significantly decrease cell adhesion and the 
absorbance readings were widely variable. The solubilized Filastatin condition revealed a decrease in cell 
adhesion of 60% and samples with Filastatin absorbed into them decreased adhesion by 80%. The 
absorbance of the Filastatin absorbed condition was not significantly different from the negative 
control. That is to say that the decrease in cell adhesion was comparable to no cells adhering to the 
silicone ring.   
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Discussion 
 This project refined incorporation methods of Filastatin into silicone to decrease C. albicans’ 
ability to adhere to silicone. The final incorporation method controlled pH and incubation time to 
maximize the final product’s antifungal properties. Tris at pH 8.5 proved to be the optimal solvent for 
the interaction between Filastatin and the silicone samples. Repeated experimentation demonstrated 
that Filastatin absorbed into silicone decreased cell adhesion by 50-80%. This result was slightly 
amplified by the addition of a polydopamine layer on top of the Filastatin at short time points; the 
average decrease rising to almost 70%. While the polydopamine layer covering Filastatin initially 
increased its effectiveness, longer incubation proved to show the opposite effect. Filastatin absorbed 
into silicone samples was the most effective method. 
 Incorporation of Filastatin into the silicone samples was demonstrated by color change (the 
clear plastic turned yellow) and was reaffirmed by testing the samples’ elution rates by absorbance 
readings when left in Tris pH 8.5. Starting with a 25 uM concentration of Filastatin, the silicone squares 
absorbed Filastatin until the concentration of the solution dropped to 3uM. When samples eluted 
Filastatin, they did so until the concentration in solution was 3uM. These results suggest that Filastatin’s 
movement into and out of silicone is controlled by a strong concentration gradient. This may not be the 
saturation point of Filastatin in silicone, but rather appears to be the point of equilibrium between the 
solution and silicone samples. It is possible that more Filastatin could move into or out of the samples if 
the starting concentration was higher.  Nonetheless, it was an effective concentration of Filastatin to 
maintain a therapeutic effect.  
Although absorption of Filastatin into silicone was consistently effective, the incorporation 
methods were not replicable using materials other than silicone. Tests on thermoplastic polyurethane 
and pellethane showed insignificant decreases in cell adhesion. These results may be in part due to the 
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cell quantification assays used; crystal violet stained the negative controls more for these plastics than it 
did when using silicone. It is possible that another cell adhesion assay would produce different results.  
 Although the silicone samples did not produce data as variable as the other plastics, initial 
adhesion assays produced somewhat inconsistent data. A large variable may have been the overnight 
culture. Originally, a colony of C. albicans was taken from a YPD (yeast extract peptone dextrose) plate 
and incubated in 0.2% glucose YNB (yeast nitrogen base) media. The next day the O.D was adjusted to 
0.3 to complete the experiment. Repeating the cell adhesion assay with different overnight cultures 
revealed that a reading of 10 OD/ml or greater before adjusting for the assay did not work well. These 
cells were presumed to be in death phase. When the initial OD of the overnight culture was 5-7 OD/ml, 
the cells grew as expected through the assay and were more consistent among replicates. These cells 
were presumably in log phase. Controlling cell growth resulted in more consistent readings, between 
replicates as well as experimental conditions on separate occasions.  
The long term assay gave the most conclusive data; it demonstrated that Filastatin that is 
absorbed into silicone retains antifungal properties for 45 hours. The polydopamine samples were wildly 
variable and resulted in adhesion values close to the positive control while the Filastatin absorbed 
samples were increasingly effective over time. One explanation for Filastatin’s increased effect was that 
a longer incubation time allowed for an increased effect in transcriptional inhibition. As cells began to 
adhere to the samples, Filastatin may have permanently blocked transcriptional factors, blocking hyphal 
morphogenesis. An increased amount of time may have allowed Filastatin to interact with more of the 
cells that tried to adhere. The adverse effect of polydopamine that was seen at later time points may be 
explained by its self-assembling properties; the polydopamine layer may have been able to remain well 
organized at short time points but began to disassemble over time. Cells that did adhere may have been 
polymerized over, trapping them and allowing them to adhere and replicate.  
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 The future of this project begins with continued experimentation on incorporation. Absorbing 
Filastatin into medical materials can be affected by things the team did not have time to look into: 
swelling the material, using other solvents, Filastatin concentration. Swelling was identified as a 
possibility but the only experimentation demonstrated that Tris buffer was more effective than water. 
The team tested buffers ranging from pH 5-10, but only two buffers were used and no other solvents 
were tested. Incorporation of Filastatin was completed at 25uM concentration, but it is possible that the 
material would retain a therapeutic effect at lower concentrations. Determining the minimum 
concentration would lead to designing a more cost effective manufacturing process.  
 The final suggestion for future work is to determine the activity of Filastatin with regards to C. 
albicans. Filastatin’s exact mechanism remains unknown. Future work could include using GFP tags to 
observe if Filastatin is taken into the cell and if it is degraded at any point. Another option is to allow 
cells to soak in Filastatin and then filter the cells out. If less Filastatin is left in solution it may show that 
Filastatin is either being taken up by the cells or at least adhering to them.   
 Improving the incorporation method would have further effects that just preventing C. albicans 
infections in patients requiring urinary catheters. The incorporation methods could have considerable 
impact on fungal and bacterial infections that begin with cell adhesion. Identifying the interaction 
between Filastatin and C. albicans would allow a target to be identified. Many pathogens cause infection 
by means of adhesion and biofilm formation; inhibiting this pathway could stop many pathogens from 
becoming infectious. The preventative measures could be applied to implanted devices other than 
urinary catheters as well. Catheters are used intravenously, and many other medically implanted devices 
are made of plastics similar to silicone. Using absorption as an incorporation method for plastics is 
simple and easily scalable. Developing this incorporation method, as well as the molecule itself, has 
broad reaching implications across medical devices and individual pathogens.  
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Figure 1: Absorbance readings at 590 nm of cell adhesion assay done on silicone squares 
A cell adhesion assay using crystal violet was performed using silicone squares. Absorbance readings of 
the six biological replicates of each condition over three separate experiments was averaged and 
normalized to the positive control. Comparison shows the percent decrease of cell adhesion.  
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Figure 2: Absorbance of cell adhesion assay on A) Pellethane and B) thermoplastic polyurethane 
The same short term cell adhesion assay was repeated using two other plastics. Absorbance values of six 
biological replicates for each experiment were averaged and normalized against the positive control. A) 
Pellethane produced inconsistent readings close to the control, suggesting incorporation is not possible. 
B) Thermoplastic polyurethane resulted in statistically significant decrease for the Filastatin absorption 
treatment, but even this was only a 28% decrease.  
A 
B 
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Figure 3: Absorbance versus Filastatin concentration correlation of Filastatin serial dilution 
Stock solution of Filastatin at 25uM was serially diluted six times. The absorbance of each solution was 
read at 400nm. The correlation is almost perfectly linear, with an R2 value of 0.9897. The best fit line for 
the absorbance readings was used to calculate the concentration of Filastatin at absorbance readings 
taken during absorption and elution testing.  
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Fig.4: Concentration of Filastatin as it is absorbed into silicone over two days 
Six silicone square samples were left in 1.5mL of 25uM Filastatin for two days. Absorbance readings 
were periodically taken at 400 nm and showed a consistent decrease in the concentration of Filastatin 
left in solution. This proved that Filastatin was being taken up by the samples and incorporated into the 
silicone.  
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Figure 5: Absorbance of Filastatin eluted from silicone with and without polydopamine layer 
Six of each silicone treated sample were left in 1.5 mL 10uM Tris pH 8.5. Absorbance readings were 
measured at 400 nm, the increase in absorbance showing that Filastatin was eluted slowly over time. 
The graph on the right shows the elution rate of samples treated with both Filastatin and polydopamine 
while the graph on the right shows the elution rate of samples that had absorbed Filastatin.  
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Figure 6: Absorbance readings from cell adhesion assay done with rings and squares side by side 
A cell adhesion assay was performed using both squares and rings cut from a silicone catheter. A) Rings 
cut from the catheter significantly decreased cell adhesion over each condition, similarly to the previous 
assays. B) Squares cut from the catheter showed lesser decrease in cell adhesion and were more difficult 
to cut consistently.  
68% 
70%
% 
 68% 
49% 
47% 
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 Figure 7: Absorbance readings from cell adhesion assay done on silicone catheter rings  
A silicone catheter was cut into rings 2mm deep. A cell adhesion assay was completed and absorbance 
readings for the crystal violet were done at 590 nm. These results were congruent with results using the 
silicon sheet; all conditions were similar and significantly different from the uncoated samples.  
 
 
 
 
 
 
 
68% 72% 71%  
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Figure 8: Absorbance readings of cell adhesion assay on silicone catheter rings over two days 
The cell adhesion assay as previously described was adapted to more closely mirror in vivo conditions. 
The starting cell count was decreased from 1.5 x 107 to 1500 cells. Incubation time was increased 
from2.5 hours to 22 hours (A) and 45 hours (B). Samples were incubated with cells at 37° C and 80 RPM. 
After treatment with crystal violet, the absorbance was taken at 590nm. These readings were 
normalized to the positive control of an uncoated sample. A) Absorbance readings of crystal violet that 
was released from cells that had adhered to silicone rings after 22 hours of incubation. The samples that 
were co-incubated with Filastatin decreased cell adhesion by 30% and the sample that with Filastatin 
absorbed into them had a 50% decrease.  Polydopamine treatments had an adverse effect. B) 
Absorbance readings at 45 hours showed that polydopamine treatments had no significant effect on cell 
adhesion. The soluble Filastatin samples had a decrease of 60% and the Filastatin absorbed samples had 
a decrease of 80%. The Filastatin absorbed sample was not significantly different from the negative 
control.  
A 
B 
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